Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2

被引:0
|
作者
D. Thirumal Kumar
L. Jerushah Emerald
C. George Priya Doss
P. Sneha
R. Siva
W. Charles Emmanuel Jebaraj
Hatem Zayed
机构
[1] Vellore Institute of Technology,Department of Integrative Biology, School of Bio Sciences and Technology
[2] Sri Ramachandra Medical College and Research Institute,Faculty of Biomedical Sciences, Technology and Research
[3] Qatar University,Department of Biomedical Sciences, College of Health and Sciences
来源
Metabolic Brain Disease | 2018年 / 33卷
关键词
D-2-hydroxyglutaric aciduria 2; D2HGDH; IDH2; Variant classification; Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
The 2-hydroxyglutaric aciduria (2-HGA) is a rare neurometabolic disorder that leads to the development of brain damage. It is classified into three categories: D-2-HGA, L-2-HGA, and combined D,L-2-HGA. The D-2-HGA includes two subtypes: type I and type II caused by the mutations in D2HGDH and IDH2 proteins, respectively. In this study, we studied six mutations, four in the D2HGDH (I147S, D375Y, N439D, and V444A) and two in the IDH2 proteins (R140G, R140Q). We performed in silico analysis to investigate the pathogenicity and stability changes of the mutant proteins using pathogenicity (PANTHER, PhD-SNP, SIFT, SNAP, and META-SNP) and stability (i-Mutant, MUpro, and iStable) predictors. All the mutations of both D2HGDH and IDH2 proteins were predicted as disease causing except V444A, which was predicted as neutral by SIFT. All the mutants were also predicted to be destabilizing the protein except the mutants D375Y and N439D. DSSP plugin of the PyMOL and Molecular Dynamics Simulations (MDS) were used to study the structural changes in the mutant proteins. In the case of D2HGDH protein, the mutations I147S and V444A that are positioned in the beta sheet region exhibited higher Root Mean Square Deviation (RMSD), decrease in compactness and number of intramolecular hydrogen bonds compared to the mutations N439D and D375Y that are positioned in the turn and loop region, respectively. While the mutants R140Q and R140QG that are positioned in the alpha helix region of the protein. MDS results revealed the mutation R140Q to be more destabilizing (higher RMSD values, decrease in compactness and number of intramolecular hydrogen bonds) compared to the mutation R140G of the IDH2 protein. This study is expected to serve as a platform for drug development against 2-HGA and pave the way for more accurate variant assessment and classification for patients with genetic diseases.
引用
收藏
页码:1699 / 1710
页数:11
相关论文
共 50 条
  • [31] CLINICAL AND MRI FINDINGS IN A CASE OF D-2-HYDROXYGLUTARIC ACIDURIA
    SUGITA, K
    KAKINUMA, H
    OKAJIMA, Y
    OGAWA, A
    WATANABE, H
    NIIMI, H
    [J]. BRAIN & DEVELOPMENT, 1995, 17 (02): : 139 - 141
  • [32] D-2-HYDROXYGLUTARIC ACIDURIA IN NEONATE WITH SEIZURES AND CNS DYSFUNCTION
    CRAIGEN, WJ
    JAKOBS, C
    SEKUL, EA
    LEVY, ML
    GIBSON, KM
    BUTLER, IJ
    HERMAN, GE
    [J]. PEDIATRIC NEUROLOGY, 1994, 10 (01) : 49 - 53
  • [33] D-2-HYDROXYGLUTARIC ACIDURIA AND COMBINED RESPIRATORY CHAIN DEFICIENCY
    Koch, J.
    Volkmar, B.
    Mayr, J. A.
    Sass, J. O.
    Sperl, W.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 124 - 124
  • [34] CLINICAL AND MRI FINDINGS IN A CASE OF D-2-HYDROXYGLUTARIC ACIDURIA
    Mesli, S.
    Villega, F.
    Colombies, B.
    Redonnet-Vernhet, I
    Lamireau, D.
    Mansour, R.
    Balestrat, S.
    Bertuletti, B.
    Espil-Taris, C.
    de Verneuil, H.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S43 - S43
  • [35] D-2-hydroxyglutaric aciduria: Evidence of clinical and biochemical heterogeneity
    Wagner, L
    Hoffmann, GF
    Jakobs, C
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (03) : 247 - 250
  • [36] MUTATIONS IN THE D-2-HYDROXYGLUTARATE DEHYDROGENASE GENE IN THREE PATIENTS WITH PHENOTYPICALLY MILD D-2-HYDROXYGLUTARIC ACIDURIA
    Struys, E. A.
    Korman, S. H.
    Salomons, G. S.
    Darmin, P. S.
    Achouri, Y.
    van Schaftingen, E.
    Verhoeven, N. M.
    Jakobs, C.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 94 - 94
  • [37] D-2-hydroxyglutaric aciduria and its response to creatine therapy
    Deivasumathy, M
    Mordekar, S
    Harpin, V
    Sharrard, M
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 : 9 - 9
  • [38] A lymphoblast model for IDH2 gain-of-function activity in D-2-hydroxyglutaric aciduria type II: Novel avenues for biochemical and therapeutic studies
    Kranendijk, M.
    Salomons, G. S.
    Gibson, K. M.
    Van Schaftingen, E.
    Jakobs, C.
    Struys, E. A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (11): : 1380 - 1384
  • [39] L2HGDH Missense Variant in a Cat with L-2-Hydroxyglutaric Aciduria
    Christen, Matthias
    Janzen, Nils
    Fraser, Anne
    Sewell, Adrian C.
    Jagannathan, Vidhya
    Guevar, Julien
    Leeb, Tosso
    Sanchez-Masian, Daniel
    [J]. GENES, 2021, 12 (05)
  • [40] Mutations identified in D-2-hydroxyglutarate dehydrogenase in 14 out of 36 unrelated patients with D-2-hydroxyglutaric aciduria
    Salomons, G. S.
    Darmin, P. S.
    Struys, E. A.
    Verhoeven, N. M.
    Abdenur, J.
    Sansaricq, C.
    Meli, C.
    Hobson, E.
    Pronicka, E.
    Dodelson de Kremer, R.
    Gissen, P.
    C, Gaba
    van der Knaap, M. S.
    Jakobs, C.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 40 - 40